EOSERA™, Inc, Fort Worth, Tex, announced the launch of a new earwax impaction solution, Earwax MD™, to hearing aid centers and audiologists at the AudiologyNOW! 2017 Conference in Indianapolis, Indiana from April 5 to 8, 2017. EOSERA states that it is the healthcare industry’s first earwax impaction solution to safely and effectively dissolve wax blockage in a single dosage.
AudiologyNOW! attendees will be able to find EOSERA at Booth #213. Participants who use the hashtag #EarwaxMDAAA on social media will be entered in a drawing to win an Apple Watch.
“We are thrilled that the AudiologyNOW! conference coincides with our April launch,” said Elyse Dickerson, founder and CEO of Eosera Inc. “We know that Earwax MD will help people worldwide with earwax impaction, especially those who are more prone to the condition such as the elderly and hearing aid users. By bringing this novel innovation to market, our goal is to improve the lives of both doctors and patients by saving people time and money. Patients can now proactively clean their ears at home which means less visits to the doctor for earwax removal. Instead of having to dig out earwax, audiologists and hearing aid centers can now fit patients for hearing aids in one visit.”
Dickerson advises patients to ask their local hearing aid centers about the product. The product will also be available on Amazon in mid-April. Audiologists and other healthcare professionals can purchase Earwax MD through distributors such as Oaktree, Warner Tech, and ADCO.
Clinical evaluations from Eosera. According to Eosera, in a clinical evaluation of Earwax MD, a total of 30 ears with moderate to severe earwax impaction were tested. Eosera reports that a single application of Earwax MD (consisting of up to two doses) not only fully cleared the impaction in 86% of test subjects, but also reduced symptoms by 82%. Common symptoms of earwax impaction include a feeling of fullness, itching, ringing of the ears, and hearing loss.
In a separate study, researchers compared Earwax MD to two other competitive systems. According to Eosera, researchers collected samples of human earwax, placed them in test tubes with each solution, and measured the solutions’ effectiveness at dissolving the wax. Using a scale of 0 (no disintegration) to 4 (complete disintegration), wax samples were evaluated and scored at 5, 10, 15, and 30 minutes. At the end of 30 minutes, Earwax MD reportedly showed significant disintegration of the wax samples (scored 3.24), while Murine Ear and Debrox barely showed any change in the wax samples (scored 0.12).
Safe for human skin. Eosera also worked with a dermatologist to ensure Earwax MD was safe on skin. Fifty (50) subjects were exposed to Earwax MD in a series of tests designed to evaluate product safety. Skin tests showed no evidence of irritation.
At AudiologyNOW! Eosera invites hearing care professionals to visit Booth #213 at the upcoming AudiologyNOW! Conference this April 5-8 in Indianapolis. Conference goers can post on social media using the hashtag #EarwaxMDAAA to enter a drawing to win one of the watches. From now until the conference ends, Eosera will put names in a drawing for every social media post with its hashtag. The second watch can be won by stopping by the Eosera to meet Dr Earwax MD who will be live at the conference.
“Take a picture with her and post on social media for a chance to win the second Apple Watch. Attendees can also simply stop by and register to win,” said Melanie Morris, marketing manager at Eosera, Inc.